Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Sami I. Said"'
Autor:
James A. Waschek, Hubert Vaudry, David Vaudry, Sami I. Said, Joseph R. Pisegna, Victor May, Marc Laburthe, Anthony Harmar, Illana Gozes, Edward J. Goetzl, Jan Fahrenkrug
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2023
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Vasoactive Intestinal Peptide Receptors [65, 66]) are activated by the endogenous peptid
Autor:
Sami I. Said
Publikováno v:
Proinflammatory and Antiinflammatory Peptides ISBN: 9781003064695
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f94dff7063fed367829a27ab39719528
https://doi.org/10.1201/9781003064695-1
https://doi.org/10.1201/9781003064695-1
Autor:
Sami I. Said
Publikováno v:
Proinflammatory and Antiinflammatory Peptides ISBN: 9781003064695
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::551785cb25cbf8f36413cd0cd5f8cbce
https://doi.org/10.1201/9781003064695-18
https://doi.org/10.1201/9781003064695-18
Purpose: To assess the clinical safety and possible effectiveness of Vasoactive Intestinal Peptide in the treatment of Acute Respiratory Distress Syndrome (ARDS) related to sepsis. Methods: Under FDA Investigational New Drug clearance, 8 patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4302dc8916de572dc24c60b1606a2986
Publikováno v:
SSRN Electronic Journal.
Purpose: To assess the clinical safety and possible effectiveness of Vasoactive Intestinal Peptide in the treatment of Acute Respiratory Distress Syndrome (ARDS) related to sepsis Methods: Under FDA Investigational New Drug clearance, 8 patients with
Autor:
Illana Gozes, Marc Laburthe, Jan Fahrenkrug, Anthony J. Harmar, Hubert Vaudry, Sami I. Said, Victor May, Edward J. Goetzl, David Vaudry, Joseph R. Pisegna, James A. Waschek
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2019
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Vasoactive Intestinal Peptide Receptors [64, 65]) are activated by the endogenous peptid
Autor:
Marc Laburthe, Jan Fahrenkrug, Sami I. Said, Anthony J. Harmar, David Vaudry, Illana Gozes, Victor May, Hubert Vaudry, Joseph R. Pisegna, James A. Waschek
Publikováno v:
British Journal of Pharmacology. 166:4-17
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are members of a superfamily of structurally related peptide hormones that includes glucagon, glucagon-like peptides, secretin, gastric inhibitory pept
Publikováno v:
European Respiratory Journal. 35:730-734
Although largely distinct and seemingly unrelated, asthma and pulmonary arterial hypertension (PAH) have important pathological features in common, including inflammation, smooth muscle contraction and remodelling. We hypothesised that these common f
Moderate Pulmonary Arterial Hypertension in Male Mice Lacking the Vasoactive Intestinal Peptide Gene
Autor:
Sayyed A. Hamidi, James A. Waschek, Sergey Lyubsky, Anthony M. Szema, Smadar Kort, Kathleen G. Dickman, Sami I. Said, John J. Chen, Ya-Ping Jiang, Richard Z. Lin
Publikováno v:
Circulation. 115:1260-1268
Background— Vasoactive intestinal peptide (VIP), a pulmonary vasodilator and inhibitor of vascular smooth muscle proliferation, has been reported absent in pulmonary arteries from patients with idiopathic pulmonary arterial hypertension (PAH). We h